


Healthcare News Roundup: Biopharmaceutical
HSMN NewsFeed - 31 Aug 2026
Lilly to Acquire Merida Biosciences to Advance Treatments for Serious Autoimmune and Allergic Diseases
Lilly to Acquire Merida Biosciences to Advance Treatments for Serious Autoimmune and Allergic Diseases
HSMN NewsFeed - 18 Aug 2026
Amygdala Neurosciences Announces FDA Clearance of Investigational New Drug (IND) Application for ANS-858
Amygdala Neurosciences Announces FDA Clearance of Investigational New Drug (IND) Application for ANS-858
